Docetaxel+Cisplatin+5-FU (DCF) Therapy as a Preoperative Chemotherapy to Advanced Esophageal Squamous Cell Carcinoma: A Single-center Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2023 at "Internal Medicine"
DOI: 10.2169/internalmedicine.9751-22
Abstract: Objective The aim of this study was to determine the safety and clinical efficacy of docetaxel+cisplatin+5-fluorouracil (DCF) as neoadjuvant chemotherapy (NAC). Methods In this single-center study, patient background and treatment outcomes (NAC efficacy assessment, NAC… read more here.
Keywords: dcf therapy; therapy; group; docetaxel cisplatin ... See more keywords
Adverse Prognostic Factors of Advanced Esophageal Cancer in Patients Undergoing Induction Therapy with Docetaxel, Cisplatin and 5-Fluorouracil.
Sign Up to like & getrecommendations! Published in 2018 at "Anticancer research"
DOI: 10.21873/anticanres.12302
Abstract: BACKGROUND/AIM The purpose of this study was to identify adverse prognostic factors for patients with advanced esophageal cancer undergoing chemotherapy with docetaxel, cisplatin and 5-fluorouracil (DCF). PATIENTS AND METHODS The study cohort comprised of 45… read more here.
Keywords: esophageal cancer; advanced esophageal; therapy; induction ... See more keywords